Steris plc attracts fresh institutional buying, shares supported by Moderate Buy consensus
29.06.2026 - 12:51:14 | ad-hoc-news.de
By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-29, 12:49.
Steris plc (IE00BFY8C754) has seen Pictet Asset Management Holding SA increase its holdings in the medical equipment provider by 9.2 percent in the first quarter, according to a recent SEC filing referenced by MarketBeat. The shares trade on the NYSE, where the stock carries a market capitalization of about 21.01 billion dollars and remains covered by several research houses with a Moderate Buy consensus.
Institutional stake and valuation metrics
MarketBeat reports that Pictet Asset Management Holding SA lifted its position in Steris plc shares by 9.2 percent during the first quarter, signaling sustained institutional interest in the NYSE-listed company. The same report cites a market capitalization of 21.01 billion dollars, a price-to-earnings ratio of 27.19 and a beta of 0.93, placing Steris in the large-cap, relatively low-volatility segment of the medical equipment sector.
According to MarketBeat, Steris shares have a 50-day simple moving average of 212.77 dollars and a 200-day simple moving average of 233.10 dollars, indicating that the shorter-term average currently sits below the longer-term trend line. The stock’s 12-month trading range runs from a low of 195.14 dollars to a high of 269.44 dollars, giving investors a documented corridor for recent volatility and performance.
Analyst ratings and earnings picture
On the analyst side, MarketBeat notes that three research analysts currently rate Steris plc shares Buy, while one assigns a Hold recommendation, resulting in a consensus rating described as Moderate Buy. The same compilation puts the average target price for the stock at 278.00 dollars, reflecting the earnings outlook and sector positioning of the infection prevention specialist. Research analysts quoted by MarketBeat expect Steris to post 11.18 dollars in earnings per share for the current fiscal year, offering a quantitative benchmark for valuation discussions.
In its most recent reported quarter on May 11, Steris disclosed earnings per share of 2.83 dollars, missing the compiled analyst consensus of 2.86 dollars by 0.03 dollars. Quarterly revenue reached 1.59 billion dollars, a figure that MarketBeat states was in line with the consensus estimate of 1.59 billion dollars, illustrating solid top-line delivery even as the bottom line came in slightly below expectations. MarketBeat adds that Steris maintains a regular dividend, with a quarterly payment of 0.63 dollars per share having been distributed on June 26 to investors of record on June 8, underlining the company’s shareholder-return policy.
All news and data on the Steris plc shares
Further updates, regulatory filings and price data on Steris plc can be found in the ad-hoc-news topic hub and on the company’s investor relations page.
How Steris plc makes its money
Steris plc generates revenue as a global provider of infection prevention, contamination control and procedural products and services for healthcare, life sciences, pharmaceutical and medical device customers. Its portfolio includes sterilization systems, endoscope reprocessing equipment and consumables, operating room products and related service contracts, which together create recurring revenue streams from hospitals and laboratories worldwide.
Where the Steris plc shares trade today
The Steris plc shares (IE00BFY8C754) trade on the NYSE under the ticker STE, with the latest compiled data from MarketBeat indicating a market capitalization of 21.01 billion dollars as of the most recent update. The price level referenced in that report aligns with a 12-month corridor between 195.14 and 269.44 dollars for the shares, with the 50-day and 200-day moving averages at 212.77 and 233.10 dollars respectively.
Key data on the Steris plc shares
- Company: STERIS plc
- ISIN: IE00BFY8C754
- WKN: Not available
- Ticker: STE
- Trading venue: NYSE
- Price (as of 2026-06-29, 12:49): 212.77 USD (50-day moving average used as indicative level)
- Market cap: 21.01 billion USD (as of latest MarketBeat update)
- Sector / industry: Health Care Equipment & Supplies
- Index membership: S&P 500 (widely tracked large-cap US index for diversified exposure)
- Next earnings date: not officially scheduled
Disclaimer: This article is for informational purposes only and does not constitute investment advice, a buy or sell recommendation, or a solicitation to purchase any securities. Data points and analyst views are based on sources cited and may change without notice.
